Replies to post #55197 on Ayala Pharmaceuticals Inc (ADXS)

[tj1912]

Hi Hovacre,

Speaking of slam dunks.. If approved by ema, would that be considered a slam dunk for the company going forward?

[ubmmg]

So far, WS puts less than 5% probability of EMA conditional approval within 18 months, and less than 1% for an approval within 10 months. This is what is baked in the current share price: very little chance of approval and they are skeptical. Why? Besides what Zach pointed out in his SA article, the lack of a distribution partner is viewed as a sign that no BP sees is approvable, at least with the current data. Once we get a partner, then the probabilities of approval would be estimated much higher. The share price would reflect that re-evaluation.

[tj1912]

Hov,

How significant is the canine approval? Not much publicity around that...even from adxs. You would think they would make a bigger deal out of it? I was hoping it would lead right into children's therapy with a pharma. Wonder if adxs is pursuing that anymore?